Lisdexamfetamine Dimesylate Capsule
Teva Pharmaceuticals USA, Inc. · Available
Open FDA's page for this record- Update type
- Reverified
- Initial posting date
- 07/14/2023
- Package NDC
- 0480-3566-01
- Generic name
- Lisdexamfetamine Dimesylate Capsule
- Contact info
- 800-545-8800
- Availability
- Available
- Update date
- 11/02/2026
- Dosage form
- Capsule
- Presentation
- Lisdexamfetamine Dimesylate, Capsule, 20 mg (NDC 0480-3566-01)
- Company name
- Teva Pharmaceuticals USA, Inc.
- Status
- Current
- Therapeutic category
- Psychiatry
- Harmonized identifiers (openFDA)
- Application number
- ANDA202802
- Brand name
- LISDEXAMFETAMINE DIMESYLATE
- Generic name
- LISDEXAMFETAMINE DIMESYLATE
- Manufacturer name
- Teva Pharmaceuticals, Inc.
- Product NDC
- 0480-3566, 0480-3565, 0480-3567, 0480-3568, 0480-3569, 0480-3570, 0480-3564
- Product type
- HUMAN PRESCRIPTION DRUG
- Route
- ORAL
- Substance name
- LISDEXAMFETAMINE DIMESYLATE
- RxCUI
- 854830, 854834, 854838, 854842, 854846, 854850, 1593856
- SPL ID
- 7a1feaa2-6b58-4aff-a45b-533ee3174e53
- SPL set ID
- c32b5dce-2de4-4db0-a4ba-d2ce3b0a32fc
- Package NDC
- 0480-3565-01, 0480-3566-01, 0480-3567-01, 0480-3568-01, 0480-3569-01, 0480-3570-01, 0480-3564-01
- UNII
- SJT761GEGS